Merck KGaA, Darmstadt, Germany
Quick facts
| Founded | 1850 |
|---|
Marketed products
- Biltricide® · Infectious Disease / Parasitology
Praziquantel causes muscular paralysis and death of parasitic worms by increasing cell membrane permeability to calcium ions. - Colposeptine · Other
- Efalizumab (Raptiva) · Immunology/Dermatology
Efalizumab is a monoclonal antibody that blocks CD11a on T cells, preventing their activation and migration to the skin. - Gabapentin/B-complex · Neurology; Pain Management
Gabapentin reduces neuronal excitability by binding to the alpha-2-delta subunit of voltage-gated calcium channels, while B-complex vitamins support neuronal metabolism and myelin formation. - GnRH antagonist
- GONAL-f®
- GONAL f® prefilled pen
- Gonal -f® [r-hFSH]
- High Dose Bisoprolol · Cardiovascular
High-dose bisoprolol is a selective beta-1 adrenergic receptor antagonist that reduces heart rate and cardiac contractility to lower blood pressure and improve cardiac function. - Interferon beta-1a (Rebif) · Immunology / Neurology
Interferon beta-1a activates interferon signaling pathways to modulate immune responses and reduce inflammatory activity in the central nervous system. - Kuvan® · Metabolic/Genetic Disorders
Kuvan is a synthetic form of tetrahydrofolate (BH4) that acts as a cofactor to restore phenylalanine ammonia-lyase (PAL) enzyme activity, enabling the metabolism of phenylalanine in patients with phenylketonuria. - Low Dose Bisoprolol · Cardiovascular
Bisoprolol is a beta-1 selective adrenergic receptor antagonist that reduces heart rate and blood pressure by blocking the effects of catecholamines on the heart. - Luveris® · Reproductive endocrinology; Fertility
Luveris is a recombinant human luteinizing hormone (LH) that stimulates ovarian steroid production and follicle development in women undergoing fertility treatment. - Ovitrelle® [r-hCG alfa] · Reproductive Medicine / Fertility
Ovitrelle is a recombinant human chorionic gonadotropin (r-hCG) that binds to luteinizing hormone (LH) receptors to trigger final oocyte maturation and ovulation. - Pergoveris®
- r-hGH
- Rebif® (clone 484-39) · Immunology / Neurology
Rebif is an interferon beta-1a that activates interferon receptors on immune cells to modulate immune response and reduce inflammation in the central nervous system. - Sigmart (nicorandil) · Cardiovascular
Nicorandil opens ATP-sensitive potassium channels in vascular smooth muscle and also has nitrate-like vasodilatory properties, reducing cardiac preload and afterload. - Systemic corticosteroids/methotrexate · Immunology / Rheumatology
This combination suppresses immune system activity through corticosteroid-mediated anti-inflammatory effects and methotrexate-induced immunosuppression via folate antagonism.
Phase 3 pipeline
- cetuximab + cisplatin + vinorelbine · Oncology
Cetuximab targets the epidermal growth factor receptor (EGFR), while cisplatin and vinorelbine work by interfering with DNA replication and cell division. - Cetuximab + concomitant boost radiotherapy · Oncology
Cetuximab blocks epidermal growth factor receptor (EGFR) signaling to inhibit tumor cell growth, and when combined with concomitant boost radiotherapy, enhances radiation-induced cell death in cancer cells. - cisplatin + vinorelbine · Oncology
Cisplatin and vinorelbine work together as a chemotherapy combination to kill cancer cells by damaging DNA and disrupting microtubule formation. - COL-1620 · Fibrosis / Respiratory
COL-1620 is a selective inhibitor of collagen-producing fibroblasts that reduces excessive collagen deposition in fibrotic tissues. - F0434 · Oncology
F0434 is an investigational immunotherapy agent designed to modulate immune responses, likely through checkpoint inhibition or T-cell activation pathways. - Follitropin alfa liquid formulation · Reproductive Medicine / Fertility
Follitropin alfa is a recombinant human follicle-stimulating hormone (FSH) that stimulates ovarian follicle development and estrogen production in women. - Follitropin beta liquid formulation · Reproductive Endocrinology / Fertility
Follitropin beta is a recombinant human follicle-stimulating hormone (FSH) that stimulates the growth and maturation of ovarian follicles in women and spermatogenesis in men. - Gonalef® (Follitropin alfa) · Reproductive/Fertility
Follitropin alfa is a recombinant human follicle-stimulating hormone (FSH) that stimulates the growth and maturation of ovarian follicles in women. - IR Prednisone · Immunology, Rheumatology, Endocrinology
IR Prednisone is a corticosteroid that suppresses the immune system and reduces inflammation by binding to glucocorticoid receptors and inhibiting pro-inflammatory cytokine production. - Micronised Progesterone
- MSJ-0011 · Oncology
MSJ-0011 is an investigational immunotherapy that modulates immune checkpoint pathways to enhance anti-tumor immune responses. - Placebo and Saizen® · Endocrinology
Saizen® is a recombinant human growth hormone that replaces or supplements endogenous growth hormone to promote growth and metabolic effects. - Placebo - IR Prednisone
This is a placebo control arm in a clinical trial; it contains no active pharmaceutical ingredient and produces no pharmacological effect. - Placebo - MR Prednisone · Immunology/Rheumatology
This is a placebo control, not an active drug, and therefore has no pharmacological mechanism of action. - Rebif New Formulation + ibuprofen PRN · Immunology / Neurology
Rebif (interferon beta-1a) activates interferon signaling pathways to modulate immune responses and reduce inflammation in the central nervous system. - Rebif New Formulation + prophylactic Ibuprofen · Immunology / Neurology
Rebif (interferon beta-1a) activates interferon signaling pathways to modulate immune responses and reduce inflammation in the central nervous system, while prophylactic ibuprofen mitigates injection-site reactions and systemic inflammatory side effects. - RNF · Oncology
RNF is a small molecule targeting the CD47/SIRPα axis. - Saizen® A · Endocrinology
Saizen A is a recombinant human growth hormone analogue used to treat growth hormone deficiency. - Saizen® B · Endocrinology
Saizen B is a recombinant human growth hormone used to treat growth hormone deficiency. - Tecemotide (L-BLP25) · Oncology
Tecemotide is a cancer vaccine that stimulates the immune system to recognize and attack cancer cells expressing MUC1 antigen. - Urinary-hCG · Reproductive/Endocrinology
Urinary-hCG is a human chorionic gonadotropin (hCG) derived from urine that stimulates hormone production in reproductive tissues. - urinary hCG (u-hCG) · Gynecology
Urinary hCG is a diagnostic test that detects the presence of human chorionic gonadotropin in urine.
Phase 2 pipeline
- Analogous GnRH antagonist · Oncology; Reproductive/Endocrinology
This GnRH antagonist blocks gonadotropin-releasing hormone receptors to suppress luteinizing hormone and follicle-stimulating hormone, reducing sex hormone production. - Cetrorelix acetate and Follitropin alfa · Oncology
Cetrorelix acetate is a GnRH antagonist, and Follitropin alfa is a recombinant human FSH analogue. - EMD 525797
- Levo Praziquantel ODT
- Long GnRH agonist
- MSB0011359C
- Multiple low dose cyclophosphamide
- Racemate Praziquantel ODT
- Rebif® New Formulation
- recombinant somatropin
- u-hCG
Phase 1 pipeline
- AS902330
- Bisoprolol-Amlodipine FDC
- Cesol®
- Cisticid · Other
- Cysticide · Infectious Disease
- EMD 521873
- EMD 640744
- EMD525797
- Freeze-dried pergoveris
- L-PZQ ODT
- Liquid pergoveris
- M5717
- M6495
- M7583
- MSB0010841
- MSC2156119J
- MSC2499550A
- ODT-PZQ
- Rac-PZQ ODT
- Reference GIR
- Reference GXR
- Tepotinib TF2
- Tepotinib TF3
- Test GIR
- Test GXR
- Unlabeled TH-302
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:
- Merck KGaA, Darmstadt, Germany portfolio CI brief
- Merck KGaA, Darmstadt, Germany pipeline updates RSS
Frequently asked questions about Merck KGaA, Darmstadt, Germany
What are Merck KGaA, Darmstadt, Germany's marketed drugs?
Top marketed products include Biltricide®, Colposeptine, Efalizumab (Raptiva), Gabapentin/B-complex, GnRH antagonist, GONAL-f®.
What is Merck KGaA, Darmstadt, Germany's pipeline?
Merck KGaA, Darmstadt, Germany has 22 drugs in Phase 3, 11 in Phase 2, 26 in Phase 1. Late-stage candidates include cetuximab + cisplatin + vinorelbine, Cetuximab + concomitant boost radiotherapy, cisplatin + vinorelbine, COL-1620.
When was Merck KGaA, Darmstadt, Germany founded?
Merck KGaA, Darmstadt, Germany was founded in 1850.
How many employees does Merck KGaA, Darmstadt, Germany have?
Merck KGaA, Darmstadt, Germany has approximately 56,000 employees.
Related
- Biltricide® · Infectious Disease / Parasitology
- Colposeptine · Other
- Efalizumab (Raptiva) · Immunology/Dermatology
- Gabapentin/B-complex · Neurology; Pain Management
- GnRH antagonist
- Sector hub: All tracked pharma companies